At ÐǺ£ÆåÅÆ, collaborations and alliances are part of our DNA and pivotal to driving innovation, accelerating development, and bringing transformative solutions to patients. Since our creation in 1999, we have worked with academia, industry peers, and research institutions to bring new therapeutic options to patients in need.
Our 25-year history is rich with partnerships that have contributed to ÐǺ£ÆåÅÆ’s achievements.
- One example is our partnership with BioNTech. This collaboration leverages operational competencies from both ÐǺ£ÆåÅÆ and BioNTech to engage and streamline our partnership goals.
- Additionally, our work with Pfizer Oncology on antibody-drug conjugate (ADC) innovation underscores our capacity to drive forward the development and commercialization of highly targeted cancer therapies.
- Another example is our broad collaboration with AbbVie. Here, we jointly develop and commercialize a bispecific antibody product and discover future antibody therapies as part of a discovery research collaboration.
These partnerships are examples of how we at ÐǺ£ÆåÅÆ are rooted in science and recognized as an innovative powerhouse where we harness our effective and productive discovery engine through collaborations.
When ÐǺ£ÆåÅÆ partners with other organizations, the combined effect is greater than the sum of individual efforts. This synergy accelerates the pace of innovation, enabling both partners to tackle more ambitious projects and achieve results faster together.
Partnerships are also invaluable for shared learning. They provide an opportunity for partners to gain new knowledge, understand different approaches, and develop a broader view of the biotech landscape. This continuous learning is essential for growth and maintaining an edge in the industry.
ÐǺ£ÆåÅÆ looks for collaborations that align with its vision of transforming the treatment of cancer and other serious diseases. Whether it’s emerging start-ups with groundbreaking ideas or established players with complementary strengths, ÐǺ£ÆåÅÆ is committed to forging alliances that make a real difference.
The journey of innovation is not a solitary one. It thrives on collaboration, diversity of thought, and shared passion. As ÐǺ£ÆåÅÆ continues to grow and navigate the exciting challenges of biotechnology, partnerships will remain a cornerstone of our strategy, driving towards new heights of success and impact.
Together, we are not just creating medicines. We’re creating hope.
